v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Revenues    
Total revenues $ 14,618,184 $ 10,421,352
Cost of revenues 7,262,219 3,243,772
Gross margin 7,355,965 7,177,580
Compensation and related benefits 6,901,583 5,306,458
Goodwill impairment charges 0 56,675,210
General and administrative 10,037,275 6,553,961
Transaction expenses 0 792,796
Total operating expenses 16,938,858 69,328,425
Net operating loss (9,582,893) (62,150,845)
Other (expense) income    
Interest expense (2,811,861) (211,459)
Other income, net 47,429 504
Change in fair value of financial instruments (1,450,271) 6,176,097
Gain on extinguishment of Equity Line of Credit (“ELOC”) 42,394 0
Loss on extinguishment of debt (221,202) (645,979)
Loss on issuance of financial instruments (668,020) (2,513,234)
Total other (expense) income, net (5,061,531) 2,805,929
Loss before (provision for) benefit from income taxes (14,644,424) (59,344,916)
(Provision for) benefit from income taxes (68,426) 1,642,901
Net loss $ (14,712,850) $ (57,702,015)
Basic loss per common share (in Dollars per share) $ (0.73) $ (5.65)
Diluted loss per common share (in Dollars per share) $ (0.73) $ (5.65)
Weighted average number of common shares outstanding, basic (in Shares) 20,143,393 10,213,036
Weighted average number of common shares outstanding, diluted (in Shares) 20,143,393 10,213,036
Subscription fees    
Revenues    
Total revenues $ 3,230,239 $ 4,115,126
Professional services and other fees    
Revenues    
Total revenues 3,102,688 2,108,307
Technical engineering fees    
Revenues    
Total revenues 1,042,593 1,980,186
Patient fees    
Revenues    
Total revenues 3,377,536 1,207,343
Telehealth fees    
Revenues    
Total revenues 3,862,628 1,003,510
Institutional fees    
Revenues    
Total revenues $ 2,500 $ 6,880